Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 318, Issue 3, pp 166–172 | Cite as

Regional variation in the alpha-adrenergic receptors in the canine resistance vessels

  • Patrick T. Horn
  • Jai D. Kohli
  • Jay J. Listinsky
  • Leon I. Goldberg


Vasoconstrictor effects of non-selective and relatively selective alpha1- and alpha2-adrenergic agonists (noradrenaline, phenylephrine, methoxamine, clonidine, and alpha-methylnora drenaline) and the inhibition of their vasoconstrictor effects by prazosin or yohimbine were studied in vivo in the renal and femoral vascular beds of pentobarbital anesthetized, beta-adrenergic and ganglion-blocked dogs. Some animals were additionally pretreated with methylphenidate to block uptake of the agonists by the nerves. In the femoral vascular bed the following results were obtained: 1. Clonidine was equipotent with noradrenaline and about 15-fold more potant than phenylephrine in reducing the blood flow. 2. Yohimbi while prazosin had practically no effect on, the induced by clonidine. 3. Vasoconstriction induced by phenylephrine or methoxamine was antagonized by prazosin but not by yohimbine. The results obtained in the renal vascular bed were as follows: 1. Clonidine was about 12-fold weaker than noradrenaline and nearly equipotent with phenylephrine in reducing blood flow. 2. Both yohimbine and prazosin were weak antagonists of the vasoconstriction induced by clonidine and tended to be additive. 3. Prazosin effectively antagonized the effects of phenylephrine or methoxamine. Noradrenaline and alpha-methylnoradrenaline caused vasoconstriction in both beds and their effects were inhibited by both antagonists which tended to be additive in either vascular bed.

These results provide further evidence that the vasoconstrictor effects of noradrenaline and other alpha-adrenergic agonists are mediated by both subtypes of alpha-adrenergic receptors in the blood vessels of the dog. Higher potency of clonidine in the femoral bed and its selective inhibition by yohimbine indicate that alpha2 subtype of adrenergic receptors predominate in this bed. Similar considerations in the reverse suggest that alpha1-adrenergic receptors predominate in the renal vascular bed of the dog. Thus, these results show that there is regional variation in the distribution of the subtypes of alpha-adrenergic receptors in the resistance vessels of the dog.

Key words

Alpha-adrenergic agonists Alpha-adrenergic antagonists Subtypes of alpha-adrenergic receptors Renal blood flow Femoral blood flow Vascular alphaadrenergic receptors Regional variation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bentley SM, Drew GM, Whiting SB (1977) Evidence for two distinct types of postsynaptic alpha-adrenoceptor. Br J Pharmacol 61:116P-117PGoogle Scholar
  2. Berthelsen S, Pettinger WA (1977) A functional basis for classification of alpha-adrenergic receptors. Life Sci 21:595–606Google Scholar
  3. Cambridge D, Davey MJ, Massingham R (1977) Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors. Br J Pharmacol 59:514P-515PGoogle Scholar
  4. Cavero I, LeFevre F, Roach AG (1977) Differential effects of prazosin on the pre- and postsynaptic alpha-adrenoceptors in the rat and dog. Br J Pharmacol 61:469PGoogle Scholar
  5. Constantine JW, Lebel W (1980) Complete blockade by phenoxybenzamine of alpha1-but not of alpha2-vascular receptors in dogs and the effects of propranolol. Naunyn-Schmiedeberg's Arch Pharmacol 314:149–156Google Scholar
  6. Constantine JW, Gunnell D, Weeks RA (1980) Alpha1- and alpha2-vascular adrenoceptors in the dog. Eur J Pharmacol 66:281–286Google Scholar
  7. Docherty JR, McGrath JC (1980) A comparison of pre- and post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 312:107–116Google Scholar
  8. Docherty JR, Madjar H, Starke K (1980) An investigation of pre- and post-synaptic alpha-adrenoceptors in the rabbit hindlimb. Br J Pharmacol 72:120P.Google Scholar
  9. Drew GM (1976) Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptors. Eur J Pharmacol 36:313–320Google Scholar
  10. Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol 67:207–215Google Scholar
  11. Dubocovich ML, Langer SZ (1974) Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: Differences in potency of phenoxybenzamine in blocking the pre- and postsynaptic adrenergic receptors. J Physiol (London) 237:505–519Google Scholar
  12. Flavahan NA, McGrath JC (1980) Blockade by yohimbine of prazosin-resistant pressor effects of adrenaline in the pithed rat. Br J Pharmacol 69:355–357Google Scholar
  13. Gillespie JS (1980) Presynaptic receptors in the autonomic nervous system. In: Szekeres L (ed) Adrenergic activators and inhibitors, part I. Springer, Berlin Heidelberg New York, pp 353–425Google Scholar
  14. Hamilton CA, Reid JL (1980) Postynaptic location of alpha2 adrenoceptors in vascular smooth muscle. Br J Pharmacol 70:63P-64PGoogle Scholar
  15. Harper B, Hughes IE, Noormohamed FH (1978) Possible differences in alpha-adrenoceptors in rabbit ileum and spleen. J Pharm Pharmacol 30:167–172Google Scholar
  16. Kobinger W, Pichler L (1980) Investigation into different types of post-and presynaptic alpha-adrenoceptors at cardiovascular sites in rats. Eur J Pharmacol 65:393–402Google Scholar
  17. Kohli JD, goldberg LI, Volkman PH, Cannon JG (1978) N,N-di-n-propyl dopamine: A qualitatively different dopamine vascular agonist. J Pharmacol Exp Ther 207:16–22Google Scholar
  18. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature (London) 24:597–598Google Scholar
  19. Langer SZ (1974) Commentary — Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1793–1800Google Scholar
  20. Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481–497Google Scholar
  21. Langer SZ (1979) Physiological and pharmacological role of presynaptic receptor systems in neurotransmission. In: Langer SZ, Starke K, Dubucovich ML (eds) Advances in the Biosciences “Presynaptic Receptors”, vol 18. Pergamon Press, Paris, pp 13–22Google Scholar
  22. Langer SZ (1980) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362Google Scholar
  23. Langer SZ, Massingham R, Shepperson NB (1980) Presence of postsynaptic alpha2-adrenoreceptors in predominantly extrasynaptic locaion in the vascular smooth muscle of the dog. Clin Sci 59:225s-228sGoogle Scholar
  24. Langer SZ, Massingham R, Shepperson NB (1981) An explanation of the resistance of the noradrenaline pressor response to prazosin blockade in vivo. Br J Pharmacol 72:121P-122PGoogle Scholar
  25. Langer SZ, Shepperson NB, Massingham RM (1981) Preferential noradrenergic innervation of alpha-adrenergic receptors in vascular smooth muscle. Hypertension (Supplement) I:I112-I118Google Scholar
  26. Listinsky JJ, Kohli JD, Goldberg LI (1980) Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed. J Pharmacol Exp Ther 215:662–667Google Scholar
  27. Madjar H, Docherty JR, Starke K (1980) An examination of pre- and postsynaptic alpha-adrenoceptors in the autoperfused rabbit hindlimb. J Cardiovasc Pharmacol 2:619–627Google Scholar
  28. McNay JL, Goldberg LI (1966) Comparison of the effects of dopamine, isoproterenol, norepinephrine, and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther 151:23–31Google Scholar
  29. Meyer MB, Goldberg LI (1966) Indirect sympathomimetic activity of recosen, a commercial heart extract. Cardiologia 49:1–10Google Scholar
  30. Moulds RFW, Jauernig RA (1977) Mechanism of prazosin collapse. Lancet 1:200–201Google Scholar
  31. Sheys EM, Green RD (1972) A quantitative study of alpha adrenergic receptors in the spleen and aorta of the rabbit. J Pharmacol Exp Ther 180:317–325Google Scholar
  32. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124Google Scholar
  33. Starke K (1979) Presynaotic modulation of catecholamine release in the central nervous system: Some open questions. In: Langer SZ, Starke K, Dubucovich ML (eds) Advances in the Biosciences “Presynaptic Receptors”, vol 18. Pergamon Press, Paris, pp 129–136Google Scholar
  34. Starke K, Langer SZ (1979) A note on terminology for presynaptic receptors. In: Langer SZ, Starke K, Dubocovich ML (eds) Advances in the Biosciences, vol 18. Presynaptic Receptors, Pergamon Press, pp 1–3Google Scholar
  35. Starke K, Montel H, Gayk W, Merker R (1974) Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 285:133–150Google Scholar
  36. Starke K, Borowski E, Endo T (1975a) Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine. Eur J Pharmacol 34:385–388Google Scholar
  37. Starke K, Endo T, Taube D (1975b) Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78Google Scholar
  38. Timmermans PBMWM, van Zwieten PA (1980) Vasoconstriction mediated by postsynaptic alpha2-adrenoceptor stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 313:17–20Google Scholar
  39. Timmermans PBMWM, Kwa HY, van Zwieten PA (1979) Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 310:189–193Google Scholar
  40. Vanhoutte PM, De Ridder W, De Mey J (1980) Characteristics of post-junctional alpha-adrenoceptors in canine arteries and veins. Fed Proc 39:1070Google Scholar
  41. Van Rossum JM (1965) Different types of sympathomimetic alpha-receptors. J Pharm Pharmacol 17:202–216Google Scholar
  42. Wikberg JES (1978) Pharmacological classification of adrenergic alpha receptors in the guinea pig. Nature 273:164–166Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • Patrick T. Horn
    • 1
  • Jai D. Kohli
    • 1
  • Jay J. Listinsky
    • 1
  • Leon I. Goldberg
    • 1
  1. 1.Departments of Pharmacological and Physiological Sciences and MedicineThe Committee on Clinical Pharmacology, The University of ChicagoChicagoUSA

Personalised recommendations